197 related articles for article (PubMed ID: 32687618)
21. ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway.
Ho L; Tan SY; Wee S; Wu Y; Tan SJ; Ramakrishna NB; Chng SC; Nama S; Szczerbinska I; Chan YS; Avery S; Tsuneyoshi N; Ng HH; Gunaratne J; Dunn NR; Reversade B
Cell Stem Cell; 2015 Oct; 17(4):435-47. PubMed ID: 26387754
[TBL] [Abstract][Full Text] [Related]
22. Triclosan stimulates human vascular endothelial cell injury via repression of the PI3K/Akt/mTOR axis.
Zhang M; Zhu R; Zhang L
Chemosphere; 2020 Feb; 241():125077. PubMed ID: 31614311
[TBL] [Abstract][Full Text] [Related]
23. Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway.
Cheng HW; Chen YF; Wong JM; Weng CW; Chen HY; Yu SL; Chen HW; Yuan A; Chen JJ
J Exp Clin Cancer Res; 2017 Feb; 36(1):27. PubMed ID: 28173828
[TBL] [Abstract][Full Text] [Related]
24. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
25. Low-level laser therapy induces human umbilical vascular endothelial cell proliferation, migration and tube formation through activating the PI3K/Akt signaling pathway.
Li Y; Xu Q; Shi M; Gan P; Huang Q; Wang A; Tan G; Fang Y; Liao H
Microvasc Res; 2020 May; 129():103959. PubMed ID: 31734375
[TBL] [Abstract][Full Text] [Related]
26. Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway.
Zhang KL; Li SM; Hou JY; Hong YH; Chen XX; Zhou CQ; Wu H; Zheng GH; Zeng CT; Wu HD; Fu JY; Wang T
Cell Mol Neurobiol; 2023 Aug; 43(6):2989-3003. PubMed ID: 37106272
[TBL] [Abstract][Full Text] [Related]
27. Tectorigenin protect HUVECs from H
Chen X; Zhang W; Sun L; Lian Y
Tissue Cell; 2021 Feb; 68():101475. PubMed ID: 33385639
[TBL] [Abstract][Full Text] [Related]
28. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
Liu Y; Wang L; Shi H
Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
[TBL] [Abstract][Full Text] [Related]
29. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
30. Apelin/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase/Akt signaling.
Zhang J; Liu Q; Hu X; Fang Z; Huang F; Tang L; Zhou S
Mol Med Rep; 2015 Sep; 12(3):3829-3834. PubMed ID: 26018184
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns.
Deniz R; Baykus Y; Ustebay S; Ugur K; Yavuzkir Ş; Aydin S
J Obstet Gynaecol; 2019 Oct; 39(7):907-912. PubMed ID: 31064239
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the endothelial apelin/APJ system by hemodynamic fluid flow.
Busch R; Strohbach A; Pennewitz M; Lorenz F; Bahls M; Busch MC; Felix SB
Cell Signal; 2015 Jul; 27(7):1286-96. PubMed ID: 25817266
[TBL] [Abstract][Full Text] [Related]
33. Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.
Wang Q; Liu J; Guo T; Liu D; Pan J
Med Sci Monit; 2019 Jan; 25():700-710. PubMed ID: 30675875
[TBL] [Abstract][Full Text] [Related]
34. Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.
Zhou C; Zou QY; Li H; Wang RF; Liu AX; Magness RR; Zheng J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3470-3479. PubMed ID: 28911139
[TBL] [Abstract][Full Text] [Related]
35. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice.
Ho L; van Dijk M; Chye STJ; Messerschmidt DM; Chng SC; Ong S; Yi LK; Boussata S; Goh GH; Afink GB; Lim CY; Dunn NR; Solter D; Knowles BB; Reversade B
Science; 2017 Aug; 357(6352):707-713. PubMed ID: 28663440
[TBL] [Abstract][Full Text] [Related]
36. The Apelinergic System in Pregnancy.
Pécheux O; Correia-Branco A; Cohen M; Martinez de Tejada B
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175743
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway.
Zheng X; Zhang W; Wang Z
J Cell Mol Med; 2019 Dec; 23(12):8314-8327. PubMed ID: 31576676
[TBL] [Abstract][Full Text] [Related]
38. MEG3 damages fetal endothelial function induced by gestational diabetes mellitus via AKT pathway.
Ye HH; Yang SH; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8553-8560. PubMed ID: 30575893
[TBL] [Abstract][Full Text] [Related]
39. Comparative Study of Elabela and Apelin on Apelin Receptor Activation Through β-Arrestin Recruitment.
Zhang H; Chen J; Shi M; Xu F; Zhang X; Gong DW
Mol Biotechnol; 2023 Mar; 65(3):394-400. PubMed ID: 35960440
[TBL] [Abstract][Full Text] [Related]
40. Elabela ameliorates neuronal pyroptosis and mitochondrial fission via APJ/ZBP1 signaling in ischemic stroke.
Shen N; Kong L; Wang X; Zhang Y; Li R; Tao C; Wang G; Xu P; Hu W
Exp Neurol; 2024 Aug; 378():114802. PubMed ID: 38679280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
